Lim Jonathan E

Average Profitability
6.92%
Insider Buys Quantity
8
Insider Buys Sum
$4.73M
Insider Sells Quantity
8
Insider Sells Sum
$3.5M

Insider Activity of Lim Jonathan E

The largest purchase of all time was on 2023-10-05 and amounted to 1000000 shares of Erasca, Inc. for $2.03M.

The largest sale of all time was on 2008-03-20 and amounted to 250000 shares of Halozyme Therapeutics, Inc. for $1.51M.

Biography of Lim Jonathan E

No biography is available at this moment.

2023-12-06PurchaseErasca, Inc.
ERAS
Chairman & CEO
278,150
0.1825%
$1.72$478,418+35.84%
2023-12-05PurchaseErasca, Inc.
ERAS
Chairman & CEO
721,850
0.4606%
$1.69$1.22M+34.29%
2023-10-05PurchaseErasca, Inc.
ERAS
Chairman & CEO
1M
0.695%
$2.03$2.03M+4.25%
2023-06-08PurchaseErasca, Inc.
ERAS
Chairman & CEO
100,000
0.0676%
$2.75$275,000-18.38%
2023-03-28PurchaseErasca, Inc.
ERAS
Chairman & CEO
100,000
0.0693%
$2.84$284,000-12.41%
2023-01-10PurchaseErasca, Inc.
ERAS
Chairman & CEO
60,000
0.0413%
$3.86$231,420-29.33%
2022-12-14PurchaseErasca, Inc.
ERAS
Chairman & CEO
40,000
0.0338%
$4.99$199,600-43.49%
2008-03-20SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
250,000
0.2968%
$6.06$1.51M-13.65%
2007-11-30SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
20,000
0.0261%
$8.24$164,796-30.9%
2007-10-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
25,000
0.0331%
$9.03$225,850-31.48%
2007-09-28SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
25,000
0.033%
$8.78$219,524-24.17%
2007-08-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
25,000
0.0322%
$8.69$217,347-25.2%
2007-07-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
20,000
0.0267%
$8.20$163,933-17.66%
2007-06-29SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
50,000
0.0701%
$9.49$474,456-27.84%
2007-05-31SaleHalozyme Therapeutics, Inc.
HALO
President, CEO
50,000
0.0697%
$10.42$521,007-26.05%
2004-08-18PurchaseHalozyme Therapeutics, Inc.
HALO
President and CEO
10,000
0.0253%
$1.61$16,100+18.01%
Total: 16
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.